Kolesnick Richard, Xing H Rosie
Laboratory of Signal Transduction, The Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
J Clin Invest. 2004 Nov;114(9):1233-7. doi: 10.1172/JCI23441.
Kinase suppressor of Ras-1 (KSR1) is a recently identified member of the EGFR-Ras-Raf-1-MAPK signaling pathway. A new study demonstrates that KSR1 protects intestinal epithelium from TNF-alpha-induced apoptosis, abrogating inflammatory bowel disease (IBD). Since its discovery, there has been disagreement as to whether KSR1 possesses intrinsic kinase activity. Using transgenic mouse models and genetically modified mouse colon epithelial cells, Polk and coworkers show that the kinase activity of KSR1 is off in normal colon epithelial cells, becoming activated only at the onset of IBD. They also provide strong evidence that KSR1 kinase activity is essential for anti-apoptotic protection of the intestinal epithelium. These new data in support of KSR1 as a kinase highlight an ongoing debate as to whether KSR1 does indeed serve as a specific kinase in transphosphorylating and transactivating c-Raf-1 toward MEK1.
Ras-1激酶抑制因子(KSR1)是表皮生长因子受体(EGFR)-Ras-Raf-1-丝裂原活化蛋白激酶(MAPK)信号通路中最近发现的一个成员。一项新的研究表明,KSR1可保护肠上皮细胞免受肿瘤坏死因子-α(TNF-α)诱导的凋亡,从而消除炎症性肠病(IBD)。自发现以来,关于KSR1是否具有内在激酶活性一直存在争议。通过转基因小鼠模型和基因改造的小鼠结肠上皮细胞,波尔克及其同事发现,KSR1的激酶活性在正常结肠上皮细胞中处于关闭状态,仅在IBD发病时被激活。他们还提供了强有力的证据,证明KSR1激酶活性对于肠上皮细胞的抗凋亡保护至关重要。这些支持KSR1作为激酶的新数据凸显了一场关于KSR1是否确实作为一种特异性激酶对c-Raf-1进行转磷酸化并使其向MEK1转激活的持续争论。